nafarelin [5535]



nafarelin


SMILES CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
InChIKey RWHUEXWOYVBUCI-ITQXDASVSA-N
Sequence XHWSYXLRPG
HELM PEPTIDE1{[Glp].H.W.S.Y.[d1-Nal].L.R.P.G.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 16
Rotatable bonds 33
Log P -1.623
Molecular weight (Da) 1321.6
Stereochemistry info unspecified

Database connections

Model (Boltz2) GnRH1

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

nafarelin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 2
Phase III 0
Phase IV 2

Database connections

Model (Boltz2) GnRH1

Sankey plot

Drug Information

Target Disease
Gene Protein Receptor family Ligand type Class Name Phase ICD11 ATC Association score